Snowball logo
logo
LABB_logo

Genomma Lab Internacional S.A.B. de C.V

Mex$15.67+Mex$0.34ย  (2.22%)
Estimate
P/E
9.2
EPS
1.71
Beta
0.128
Growth
Revenue, YoY
-0.21%
Net income, YoY
-24.91%
FCF, YoY
202.33%
Forecast
P/E (FWD)
7.9
EPS (FWD)
1.975
Dividends
Dividend yield
5.11%
Annual payout
Mex$0.80
Next ex. div date
December 29, 26
Payout
37.94%
Dividend growth streak
2 y
Div.rating
About the company
Ticker
LABB
ISIN
MX01LA010006
Country
Mexico
Sector (GICS)
Healthcare
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Frequently asked questions

What sector does Genomma Lab Internacional S.A.B. de C.V (LABB) operate in?

Genomma Lab Internacional S.A.B. de C.V belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Genomma Lab Internacional S.A.B. de C.V (LABB) current stock price?

As of the latest data, Genomma Lab Internacional S.A.B. de C.V stock price is MX$15.67, with a previous close of MX$15.33. Genomma Lab Internacional S.A.B. de C.V gained MX$0.34 in the last trading session, representing a 2.22% increase.

What is Genomma Lab Internacional S.A.B. de C.V (LABB) current market capitalization?

Genomma Lab Internacional S.A.B. de C.V market cap is approximately 15.32 billion.

What is Genomma Lab Internacional S.A.B. de C.V (LABB) Earnings Per Share (EPS)?

The trailing EPS is MX$1.71, and the forward EPS is MX$1.98.

What is Genomma Lab Internacional S.A.B. de C.V (LABB) Price-to-Earnings (P/E) ratio?

Genomma Lab Internacional S.A.B. de C.V current P/E ratio is 9.16, with a forward P/E of 7.93.

What is Genomma Lab Internacional S.A.B. de C.V (LABB) EBITDA?

Genomma Lab Internacional S.A.B. de C.V EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 801.76 million.

Does Genomma Lab Internacional S.A.B. de C.V (LABB) pay dividends?

Yes. Genomma Lab Internacional S.A.B. de C.V pays quarterly dividends with an annualized yield of 5.11% and an estimated annual payout of MX$0.80 per share.

When is the next ex-dividend date for Genomma Lab Internacional S.A.B. de C.V (LABB)?

The next ex-dividend date is scheduled for December 29, 2026.

How did Genomma Lab Internacional S.A.B. de C.V (LABB) perform in its most recent earnings report?

In the last report (September 30, 2026), Genomma Lab Internacional S.A.B. de C.V posted an EPS surprise of -19.57% and a revenue surprise of -2.26%.

What is Genomma Lab Internacional S.A.B. de C.V (LABB) beta (volatility) score?

Genomma Lab Internacional S.A.B. de C.V has a beta of 0.128, indicating lower volatility than the overall market.